Navegando por Palavras-chave "Hipertrofia Gengival"

Agora exibindo 1 - 2 de 2
  • Nenhuma Miniatura disponível
    Item
    Somente Metadadados
    A eficacia do laser de baixa potencia como agente terapeutico na hipertrofia gengival medicamentosa em ratos
    (Universidade Federal de São Paulo (UNIFESP), 2009) Mattei, Daniel [UNIFESP]
  • Imagem de Miniatura
    Item
    Acesso aberto (Open Access)
    Estudo da resposta inflamatória em pacientes com epilepsia e hipertrofia gengival por uso de DAEs após terapia com laser de diodo
    (Universidade Federal de São Paulo (UNIFESP), 2017-01-31) Milena, Sheila Parreira [UNIFESP]; Scerni, Debora Amado [UNIFESP]; http://lattes.cnpq.br/3964840204818021; http://lattes.cnpq.br/6136397596258479; Universidade Federal de São Paulo (UNIFESP)
    Epilepsy affects around 70 million people representing an important public health issue and its treatment implies appropriate seizures control with minimal adverse effects. The treatment is done with the antiepileptic drugs (AEDs), being the most used, carbamazepine (CBZ), phenytoin (PHT) and valproic acid (VPA) causing gingival enlargement (GE). PHT is related to HG around 50% of patients who needs odontology treatment. Objectives: This study evaluated the effectiveness of laser therapy in the treatment of GE by use of AEDs, after conventional periodontal treatment in a group of patients with hard-to-control epilepsy with polytherapy, using clinical indexes to verify reduction of GE after the dental treatment and dosage of inflammatory mediators throughout the salivary treatment. Methods: Fifteen patients were selected between 17 and 60 years old who made continuous use of AEDs for more than twelve months without periodontal treatment for at least six months and who had moderate to severe GE. Eleven patients received, in addition to the conventional treatment, laser therapy in selected parameters and constituted 0.5 Joule and groups 1.0 Joule of energy applied to each session. The other four patients received only basic periodontal treatment and composed the placebo group. To quantify the GE was used the index of Seymour, and the dimensions of the gingival papillae were measured in millimeters on plaster models, before and after the proposed protocol, using a precision caliper. Results: The papillae inferior responded favorably to the clinical protocol, and the 1.0 J presented better results compared to 0.5 J protocol and relation to the placebo group. The index of Seymour showed that there were no statistically significant differences between the groups and even between the observation periods (before and after). It has been found that even patients in the placebo group, who received only basic periodontal therapy with oral hygiene instructions, have improved the clinical conditions, with a decrease of bleeding, edema and inflammatory conditions, indicating that the basic periodontal procedures should be applied in all conditions regardless of laser therapy for the improvement of the clinical conditions. Conclusion: The study leads to conclude the existence of important benefits to patients receiving laser therapy when compared with the placebo group, because the reduction in gingival dimension and rise reducing the inflammatory clinical standards. It was concluded that the dose of 1.0 J is more effective. Despite the conclusions favorable to the adoption of laser therapy in cases of GE studied, in some severe cases surgical intervention was required, in addition to the application of the dose of 1.0 J.